We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Lab-on-a-Chip Platform Designed for Detection of Pathogens

By LabMedica International staff writers
Posted on 04 Apr 2017
Print article
Image: Controlling magnetic nanoparticles through a microfluidic chip – produced by the rapid prototyping method – with the aid of magnets that are arranged above and below the microfluidic chip (Photo courtesy of the Fraunhofer Institute for Cell Therapy & Immunology).
Image: Controlling magnetic nanoparticles through a microfluidic chip – produced by the rapid prototyping method – with the aid of magnets that are arranged above and below the microfluidic chip (Photo courtesy of the Fraunhofer Institute for Cell Therapy & Immunology).
A team of German bioengineers has developed an integrated and automated lab-on-a-chip platform for sample preparation and nucleic acid-based detection of pathogens in various liquid media.

Since DNA-based detection of the pathogens in liquid samples demands many complex steps, various pieces of equipment, and experienced personnel, investigators at Fraunhofer Institute for Cell Therapy & Immunology developed an innovative prototype lab-on-a-chip platform capable of automating the process in a single instrument.

The system includes a microfluidic cartridge (lab-on-a-chip) and an external tabletop instrument. The simple linear design of the cartridge is based on stationary microfluidics, which does not require valves or actuators. This concept is realized via the implementation of functionalized magnetic beads for pathogen isolation and DNA extraction.

The external instrument manages bead transportation and temperature control in the reaction chambers in a user-independent mode, and the user-friendly software allows adjusting these processes as required. The detection of the amplified product is performed with a LED-based optical unit that provides the readout of the fluorescent signal.

The investigators demonstrated proof-of-concept by detecting E. coli and Salmonella as two model pathogens in spiked liquid samples via loop-mediated isothermal amplification (LAMP) and PCR. They worked with one-milliliter samples but stated that this volume could be easily scaled up.

"We were motivated by the existing need for making the molecular analysis of complex samples much simpler for the users," said first author Dr. Natalia Sandetskaya, a researcher in the nanotechnology unit at Fraunhofer Institute for Cell Therapy & Immunology. "Our particular applied interest is the detection of the pathogens in blood; for instance in sepsis, when only a few microorganisms must be rapidly found in a large volume of blood. Although our current prototype of the platform will need further development for this application, we have already demonstrated a high level of integration of very diverse processes without making the system overly complex."

Details of the device were published in the March 22, 2017, online edition of the journal Future Science OA.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.